Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Class I Recall for Cancer Drug
01/31/2024
A Class I recall has been issued for 3546 vials of bleomycin for injection distributed by Hospira Inc., a Pfizer company, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement Report. The recall was initiated...
A Class I recall has been issued for 3546 vials of bleomycin for injection distributed by Hospira Inc., a Pfizer company, according to the January 31, 2024, US Food and Drug Administration (FDA) Enforcement Report. The recall was initiated...
A Class I recall has been issued...
01/31/2024
Pharmacy Learning Network
News
Will Popular Weight Loss Drugs Increase Eating Disorders?
03/01/2024
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the...
03/01/2024
Pharmacy Learning Network
News
Class I Recall for Injection
04/05/2024
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
Obstetric Drug Recalled for Subpotency
05/09/2024
Amneal Pharmaceuticals of New York is recalling 2784 bottles of methylergonovine maleate tablets because they are subpotent.
Amneal Pharmaceuticals of New York is recalling 2784 bottles of methylergonovine maleate tablets because they are subpotent.
Amneal Pharmaceuticals of New...
05/09/2024
Pharmacy Learning Network
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
News
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
10/02/2023
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training...
10/02/2023
Psych Congress Network
News
Defective Containers Prompt Eye Drop Recall
05/15/2024
Reports of defective containers have prompted FDC Limited to recall 4 lots of timolol maleate ophthalmic solution distributed in New Jersey.
Reports of defective containers have prompted FDC Limited to recall 4 lots of timolol maleate ophthalmic solution distributed in New Jersey.
Reports of defective containers...
05/15/2024
Pharmacy Learning Network
Brain health
News
Environmental Pollutants Linked With Increased ALS Risk, Mortality
11/21/2023
An environmental risk score was associated with amyotrophic lateral sclerosis (ALS) risk and mortality in a Michigan cohort.
An environmental risk score was associated with amyotrophic lateral sclerosis (ALS) risk and mortality in a Michigan cohort.
An environmental risk score was...
11/21/2023
Neurology
News
Meta-Analysis Supports COVID-19 Vaccines for Adults of All Ages
02/22/2023
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that...
02/22/2023
First Report Managed Care
News
Treatment Preferences, Drivers Vary Widely Among Patients With Relapsing MS
04/24/2023
When it comes to choosing treatments for patients with relapsing multiple sclerosis, there can be high variability in the importance patients place on different treatment factors, according to researchers.
When it comes to choosing treatments for patients with relapsing multiple sclerosis, there can be high variability in the importance patients place on different treatment factors, according to researchers.
When it comes to choosing...
04/24/2023
First Report Managed Care
News
Adding Anti-CD20 Monoclonal Antibody to BTKi Therapy Superior to BTKi Alone in Patients With CLL
07/14/2023
New research indicates that adding an anti-CD20 monoclonal antibody to a BTK inhibitor in patients with untreated or relapsed/refractory CLL could provide significantly superior efficacy with an equally safe profile.
New research indicates that adding an anti-CD20 monoclonal antibody to a BTK inhibitor in patients with untreated or relapsed/refractory CLL could provide significantly superior efficacy with an equally safe profile.
New research indicates that...
07/14/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use